You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 136 No. 8, August 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (6)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Hematology/ Hematologic Malignancies
 •Leukemias/ Lymphomas
 •Immunologic Disorders
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Cutaneous {gamma}{delta} T-Cell Lymphomas—How and Why Should They Be Recognized?

Arch Dermatol. 2000;136:1052-1054.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

IN THIS issue of the ARCHIVES, Toro and coworkers1 report the clinicopathologic features of 3 adult male patients with cutaneous {gamma}{delta} T-cell lymphomas (CTCLs) involving the skin. These patients were distinguished by multiple plaques, tumors, and subcutaneous nodules distributed over their extremities. The lesions showed histologic evidence of epidermotropism, dermal and subcutaneous infiltration by atypical lymphocytes without cerebriform nuclei. The tumor cells had a distinct immunophenotype expressing the {gamma}{delta} T-cell receptor (TCR) heterodimer instead of the more common {alpha}{beta} TCR heterodimer. In addition, the tumor cells had a cytotoxic profile, expressing T-cell intracellular antigen 1 (TIA-1), granzyme B, and perforin. Importantly, all 3 patients with {gamma}{delta} CTCL had an aggressive clinical course with resistance to various chemotherapies. Similar results have been reported in the literature for patients with this uncommon type of lymphoma.2-5

Because of its poor prognosis and resistance to chemotherapy and radiation, it is important to distinguish {gamma}{delta} CTCLs from mycosis fungoides (MF) . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

{gamma}{delta} T-Cell Lymphoma of the Skin: A Clinical, Microscopic, and Molecular Study
Jorge R. Toro, Micheal Beaty, Lynn Sorbara, Maria L. Turner, Jeffrey White, Douglas W. Kingma, Mark Raffeld, and Elaine S. Jaffe
Arch Dermatol. 2000;136(8):1024-1032.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.